Sorry, you need to enable JavaScript to visit this website.

Featured Stories

Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business

Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world. Every year, we take stock of the impact our work has on the world, the environment, and people themselves in our Impact Report.

Photograph of a woman lifting a child holding a toy plane against a cloudy sky thumbnail

Multiple Myeloma: Shedding Light on a Rare but Complex Blood Cancer

Donna is more than a cancer patient: Donna is a wife, mother, grandmother, sister, and friend who has a full life outside of treatment. Her journey with multiple myeloma has revealed depths of resilience and strength that have long served her in all of those roles.

Photograph of a doctor explaining a medical diagram to a seated patient in an exam room thumbnail

Menstrual Migraine Explained: Why They Happen and What Can Help

For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.

Photograph of a person indoors holding their head with both hands, looking stressed thumbnail

Press Releases

Categories

Keywords

  • All Keywords

April 2022

March 2022

Resource Library

Resource Library

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits Details
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Contact Pfizer Media Relations

Media Contacts

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]